Susquehanna International Group
ACIU icon

Susquehanna International Group’s AC Immune ACIU Stock Holding History

Susquehanna International Group’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Buy
42,900
+4,500
+12% +$14K ﹤0.01% 12227
2025
Q4 		$121K Buy
+38,400
New +$121K ﹤0.01% 11348
2025
Q1 		– Sell
-23,700
Closed -$64K – 12370
2024
Q4 		$64K Sell
23,700
-99,700
-81% -$312K ﹤0.01% 11577
2024
Q3 		$466K Sell
123,400
-26,500
-18% -$92.5K ﹤0.01% 8625
2024
Q2 		$598K Buy
149,900
+64,700
+76% +$214K ﹤0.01% 7837
2024
Q1 		$252K Buy
85,200
+18,400
+28% +$66K ﹤0.01% 10102
2023
Q4 		$334K Buy
66,800
+40,000
+149% +$129K ﹤0.01% 9603
2023
Q3 		$76.4K Buy
26,800
+3,300
+14% +$10K ﹤0.01% 11094
2023
Q2 		$69.6K Buy
+23,500
New +$51.3K ﹤0.01% 11185
2022
Q4 		– Sell
-22,500
Closed -$71K – 12259
2022
Q3 		$71K Buy
22,500
+6,000
+36% +$18.9K ﹤0.01% 11975
2022
Q2 		$60K Sell
16,500
-84,100
-84% -$288K ﹤0.01% 11862
2022
Q1 		$402K Buy
100,600
+84,300
+517% +$365K ﹤0.01% 9530
2021
Q4 		$81K Sell
16,300
-154,200
-90% -$896K ﹤0.01% 12273
2021
Q3 		$1.14M Sell
170,500
-23,600
-12% -$169K ﹤0.01% 7220
2021
Q2 		$1.54M Buy
194,100
+20,900
+12% +$144K ﹤0.01% 6563
2021
Q1 		$1.32M Buy
173,200
+11,300
+7% +$80.7K ﹤0.01% 6995
2020
Q4 		$837K Buy
161,900
+64,200
+66% +$328K ﹤0.01% 7127
2020
Q3 		$477K Buy
+97,700
New +$701K ﹤0.01% 7780

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group's ACIU Position: Q1 2026 in Review

Susquehanna International Group reduced its AC Immune (ACIU) stake by 40% in Q1 2026, selling an estimated $181K and leaving 89,262 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #11303.

Susquehanna International Group first reported a position in ACIU in Q2 2020 and has held it in 14 quarters since. The position peaked at $686K in Q4 2020. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • Susquehanna International Group held 89,262 shares of AC Immune worth $245K as of Q1 2026.
  • Susquehanna International Group sold 58,363 AC Immune shares in Q1 2026, an estimated $181K.
  • AC Immune made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11303 holding.
  • Susquehanna International Group first reported a position in AC Immune in Q2 2020 and has held it in 14 quarters since.
  • Susquehanna International Group's AC Immune position peaked at $686K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.